MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
0.6391
-0.0109 (-1.68%)
Aug 25, 2025, 4:00 PM - Market closed
MetaVia Market Cap
MetaVia has a market cap or net worth of $15.73 million as of August 25, 2025. Its market cap has decreased by -15.90% in one year.
Market Cap
15.73M
Enterprise Value
-2.15M
1-Year Change
-15.90%
Ranking
Category
Stock Price
$0.64
Market Cap Chart
Since August 5, 2016, MetaVia's market cap has decreased from $84.50M to $15.73M, a decrease of -81.39%. That is a compound annual growth rate of -16.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 15.70M | -10.29% |
| Dec 31, 2024 | 17.50M | -2.23% |
| Dec 29, 2023 | 17.90M | 280.85% |
| Dec 30, 2022 | 4.70M | -85.49% |
| Dec 31, 2021 | 32.40M | -62.41% |
| Dec 31, 2020 | 86.20M | 1,557.69% |
| Dec 31, 2019 | 5.20M | -55.17% |
| Dec 31, 2018 | 11.60M | -86.27% |
| Dec 29, 2017 | 84.50M | 16.23% |
| Dec 30, 2016 | 72.70M | -13.96% |
| Aug 5, 2016 | 84.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |